Cookie Policy: This site uses cookies to improve your experience. You can find out more about our use of cookies in our Privacy Policy. By continuing to browse this site you agree to our use of cookies.
SynKinase
NVP-BSK805 dihydrochloride
CHF 0.00
In stock
SYN-1136-M0011 mgCHF 234.00
SYN-1136-M0055 mgCHF 355.00
SYN-1136-M01010 mgCHF 497.00
SYN-1136-M05050 mgCHF 1'348.00
SYN-1136-M100100 mgINQ
| Product Details | |
|---|---|
| Synonyms | NVPBSK805 |
| Product Type | Chemical |
| Properties | |
| Formula | C27H28F2N6O . 2HCl |
| MW | 490.6 . 72.9 |
| CAS | 1092499-93-8 (free base) |
| Purity Chemicals | ≥95% |
| Appearance | Solid. |
| Solubility | Soluble in DMSO or ethanol. |
| Declaration | Manufactured by SynKinase. |
| Other Product Data |
Target: JAK2 | Kinase Group: PTK | Substrate: Tyrosine Click here for Original Manufacturer Product Datasheet Our product description may differ slightly from the original manufacturers product datasheet. |
| InChi Key | NUOCAPALWRHKCU-UHFFFAOYSA-N |
| Shipping and Handling | |
| Shipping | AMBIENT |
| Short Term Storage | +4°C |
| Long Term Storage | -20°C |
| Use/Stability | Stable for at least 2 years after receipt when stored at -20°C. |
| Documents | |
| MSDS |
 Download PDF |
| Product Specification Sheet | |
| Datasheet |
Download PDF |
Description
NVP-BSK805 is a potent and selective quinoxaline JAK2 inhibitor with IC(50) values of 0.48, 0.56 and 0.58nM for JAK2 JH1, FL JAK (V617F) and FL JAK2 wt, respectively.
Product References
- Potent and selective inhibition of polycythemia by the quinoxaline JAK2 inhibitor NVP-BSK805: F. Baffert, et al.; Mol. Cancer Ther. 9, 1945 (2010)
- Effects of Jak2 Type 1 Inhibitors NVP-BSK805 and NVP-BVB808 on Jak2 Mutation-Positive and Bcr-Abl-Positive Cell Lines: F. Ringel, et al.; Acta Haematol. 132, 75 (2014)
Related Products
